Baxter (BAX) Tops Q4 EPS by 5c, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Baxter Reports 2018 Fourth-Quarter and Full-Year Results
January 31, 2019 7:15 AM ESTFourth-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 5 percent on an operational basis Fourth-quarter GAAP earnings per share (EPS) of $0.66; adjusted EPS of $0.78 increased 22 percent Full-year revenue of $11.1 billion increased 5 percent on a reported basis and 3 percent on an operational basis Full-year GAAP earnings per share were $2.99; adjusted EPS of $3.05 increased 23 percent
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today reported results... More
